Jo Pharma Limited - Company Profile

It is a healthcare public limited company based in Delhi, Delhi, India, established in 2015.
2015 Delhi, Delhi, India Active
Last Updated:
Access Report
About Jo Pharma Limited

Jo Pharma Limited, a active public limited company, was established on 12 December 2015 in Delhi, Delhi, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U23109DL2015PLC288456. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹3.70 Cr.

Formerly known as Jindal Omran Pharma Private Limited, J.O. Pharma Private Limited. It upholds a compliant status. Its leadership includes Rakshit Jindal (Director), Ankit Jindal (Director), Suresh Baid (Director). Past directors included Shakun Jindal, Suresh Baid, Mustafa Aziz Rahi. It holds ₹13.76 Cr open charges and ₹9.56 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-7/3, Safdarjung Enclave, Opposite Deer Park, Delhi, Delhi, 110029.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U23109DL2015PLC288456

  • Registration Number

    288456

  • Incorporation Date

    12 December 2015

  • Authorized Capital

    ₹5.50 Cr

  • Paid-Up Capital

    ₹3.70 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 Cr
  • Paid Up Capital ₹ 3.70 Cr
  • Company Age 10 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 13.76 Cr
  • Satisfied Charges ₹ 9.56 Cr
  • Revenue Growth **** 18.38%
  • Profit Growth **** 36.61%
  • Ebitda **** 284.46%
  • Net Worth 34.77%
  • Total Assets -23.10%
Company report

Jo Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Jo Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jo Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Rakshit Jindal Director 12 Dec 2015 Current
Ankit Jindal Director 12 Dec 2015 Current
Suresh Baid Director 22 Aug 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Jan 2022 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 28 Feb 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jo Pharma.

Jo Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.38% increase. The company also saw a substantial improvement in profitability, with a 36.61% increase in profit. The company's net worth Soared by an impressive increase of 34.77%.

Jo Pharma revenue growth over time
Jo Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 18.38%
*******
*******
*******
*******
Revenue from Operations
*******
 18.73%
*******
*******
*******
*******
Total Assets
*******
 -23.10%
*******
*******
*******
*******
Profit or Loss
*******
 36.61%
*******
*******
*******
*******
Net Worth
*******
 34.77%
*******
*******
*******
*******
EBITDA
*******
 284.46%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jo Pharma?

Unlock access to Jo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹137,600,000.00

Satisfied Charges

₹95,556,500.00

Charges Breakdown by Lending Institutions
  • Others : 11.65 Cr
  • Axis Bank Limited : 2.11 Cr
Latest Charge Details
Date Lender Amount Status
18 Mar 2025 Axis Bank Limited ₹1.80 Cr Open
28 Sep 2023 Others ₹11.65 Cr Open
19 Nov 2019 Axis Bank Limited ₹3.10 M Open
19 Aug 2022 Others ₹5.00 Cr Satisfied
26 Apr 2022 Axis Bank Limited ₹4.56 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Jo Pharma?

Unlock and access historical data on people associated with Jo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jo Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jo Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Jo Pharma Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Jo Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Charges

    Progress on A charge registered on 26 Apr 2022 via Charge ID 100593834 with Axis Bank Limited was fully satisfied on 26 Mar 2025. was documented.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 1.80 Cr with Charge ID 101101664 was registered on 18 Mar 2025. was recorded as a recent event.

  • Director Appointment

    The activity Suresh Baid was appointed as a Director was appointed as a Director on 22 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Charges

    A charge with Others amounted to Rs. 11.65 Cr with Charge ID 100788171 was registered on 28 Sep 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jo Pharma Limited?

The CIN of Jo Pharma Limited is U23109DL2015PLC288456.

Where is Jo Pharma Limited headquartered?

Jo Pharma Limited is headquartered at B-7/3, Safdarjung Enclave, Opposite Deer Park, Delhi, Delhi, 110029.

When was Jo Pharma Limited incorporated?

Jo Pharma Limited was incorporated on 12 December 2015.

Who are the current directors of Jo Pharma Limited?

The current directors of Jo Pharma Limited are

What is the primary industry of Jo Pharma Limited?

The primary industry of Jo Pharma Limited is Manufacturing.

Is Jo Pharma Limited a listed company?

Jo Pharma Limited is unlisted.

What is the capital structure of Jo Pharma Limited?

The authorized capital of Jo Pharma Limited is ₹5.50 Cr, and the paid-up capital is ₹3.70 Cr.

What is the compliance status of Jo Pharma Limited?

The compliance status of Jo Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available